- Home
- ISPR vs ALEC Comparison
ISPR vs ALEC Comparison
Compare ISPR & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ISPR
- ALEC
- Stock Information
- Founded
- ISPR 2019
- ALEC 2013
- Country
- ISPR United States
- ALEC United States
- Employees
- ISPR N/A
- ALEC N/A
- Industry
- ISPR Medicinal Chemicals and Botanical Products
- ALEC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ISPR Health Care
- ALEC Health Care
- Exchange
- ISPR Nasdaq
- ALEC Nasdaq
- Market Cap
- ISPR 152.0M
- ALEC 124.0M
- IPO Year
- ISPR 2023
- ALEC 2019
- Fundamental
- Price
- ISPR $3.06
- ALEC $2.35
- Analyst Decision
- ISPR Strong Buy
- ALEC Buy
- Analyst Count
- ISPR 2
- ALEC 8
- Target Price
- ISPR $10.00
- ALEC $4.50
- AVG Volume (30 Days)
- ISPR 47.6K
- ALEC 1.6M
- Earning Date
- ISPR 09-19-2025
- ALEC 08-07-2025
- Dividend Yield
- ISPR N/A
- ALEC N/A
- EPS Growth
- ISPR N/A
- ALEC N/A
- EPS
- ISPR N/A
- ALEC N/A
- Revenue
- ISPR $144,700,345.00
- ALEC $81,130,000.00
- Revenue This Year
- ISPR N/A
- ALEC N/A
- Revenue Next Year
- ISPR $35.39
- ALEC $196.86
- P/E Ratio
- ISPR N/A
- ALEC N/A
- Revenue Growth
- ISPR N/A
- ALEC 46.77
- 52 Week Low
- ISPR $2.09
- ALEC $0.87
- 52 Week High
- ISPR $7.79
- ALEC $6.37
- Technical
- Relative Strength Index (RSI)
- ISPR 66.49
- ALEC 60.10
- Support Level
- ISPR $2.74
- ALEC $2.31
- Resistance Level
- ISPR $3.43
- ALEC $2.55
- Average True Range (ATR)
- ISPR 0.19
- ALEC 0.22
- MACD
- ISPR 0.05
- ALEC 0.01
- Stochastic Oscillator
- ISPR 82.67
- ALEC 63.16
About ISPR Ispire Technology Inc.
Ispire Technology Inc is engaged in the research and development, design, commercialization, sales, marketing, and distribution of branded e-cigarettes and cannabis vaping products. The company sells its cannabis vaping in the United States, Europe, Canada, and South Africa.
About ALEC Alector Inc.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.